Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs.
More than a dozen recipients have been awarded part of the grants, including Massachusetts General Hospital, Fred Hutchinson Cancer Research Center, the Foundation for the National Institutes of Health, Johns Hopkins University, University of Zurich Institute of Medical Virology, Aarhus University Hospital, University of KwaZulu-Natal, Case Western Reserve University School of Medicine, AIDS Foundation of Chicago, Project Inform and My Brother’s Keeper, Inc.
“We know from decades of work addressing the issue of HIV/AIDS that there is no one-size-fits-all solution,” William Lee, executive vice president of Gilead Sciences, said. “Through partnerships with dedicated and results-driven organizations, our goal is to help in the discovery and development of safe and effective cure.”
The funds are enough to cover three years’ worth of research in translatonal studies, efficacy studies and community perspectives of an HIV cure.
“We are excited about the potential of these projects and are looking forward to seeing the results and learnings that emerge from them,” Lee said.
Gilead Sciences awards $22 million in HIV research funds
Alerts Sign-up